Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Suitability of Two Flavours of a High-energy, Low-protein Formula (Renalive® LP) in Chronic Kidney Disease Stage 3b-5 Outpatients in Taiwan

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06892249
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:13.493304+00:00
Published At
2026-03-16T00:00:00+00:00
Record Updated At
2026-03-16
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["CKD", "Low Protein Dietary Intake", "Malnutrition (Calorie)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-03-16"
protocolSection.identificationModule.nctId
"NCT06892249"
protocolSection.identificationModule.officialTitle
"Suitability of Two Flavours of a High-energy, Low-protein Formula (Renalive\u00ae LP) in Chronic Kidney Disease Stage 3b-5 Outpatients in Taiwan"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • CKD (protocolSection.conditionsModule.conditions)
  • Low Protein Dietary Intake (protocolSection.conditionsModule.conditions)
  • Malnutrition (Calorie) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.